| Title | NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity. | | Author(s) | Baron A, Montagne A, Cassé F, Launay S, Maubert E, Ali C, Vivien D | | Institution | [1] INSERM, INSERM U919, Serine Proteases and Pathophysiology of the neurovascular Unit (SP2U), Cyceron, University of Caen Basse-Normandie, Caen Cedex F-14074, France [2] CNRS, UMR CNRS 6232 Ci-NAPs 'Center for imaging - Neurosciences and Application to Pathologies', Cyceron, Caen Cedex F-14074, France. | | Source | Cell Death Differ 2009 Nov 13. | | Abstract | Although the molecular bases of its actions remain debated, tissue-type plasminogen activator (tPA) is a paradoxical brain protease, as it favours some learning/memory processes, but increases excitotoxic neuronal death. Here, we show that, in cultured cortical neurons, tPA selectively promotes NR2D-containing N-methyl-D-aspartate receptor (NMDAR)-dependent activation. We show that tPA-mediated signalling and neurotoxicity through the NMDAR are blocked by co-application of an NR2D antagonist (phenanthrene derivative (2S(*), 3R(*))-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid, PPDA) or knockdown of neuronal NR2D expression. In sharp contrast with cortical neurons, hippocampal neurons do not exhibit NR2D both in vitro and in vivo and are consequently resistant to tPA-promoted NMDAR-mediated neurotoxicity. Moreover, we have shown that activation of synaptic NMDAR prevents further tPA-dependent NMDAR-mediated neurotoxicity and sensitivity to PPDA. This study shows that the earlier described pro-neurotoxic effect of tPA is mediated by NR2D-containing NMDAR-dependent extracellular signal-regulated kinase activation, a deleterious effect prevented by synaptic pre-activation.Cell Death and Differentiation advance online publication, 13 November 2009; doi:10.1038/cdd.2009.172. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19911010 |
|
